Unknown

Dataset Information

0

Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.


ABSTRACT: Anti-cancer uses of non-oncology drugs have occasionally been found, but such discoveries have been serendipitous. We sought to create a public resource containing the growth inhibitory activity of 4,518 drugs tested across 578 human cancer cell lines. We used PRISM, a molecular barcoding method, to screen drugs against cell lines in pools. An unexpectedly large number of non-oncology drugs selectively inhibited subsets of cancer cell lines in a manner predictable from the cell lines' molecular features. Our findings include compounds that killed by inducing PDE3A-SLFN12 complex formation; vanadium-containing compounds whose killing depended on the sulfate transporter SLC26A2; the alcohol dependence drug disulfiram, which killed cells with low expression of metallothioneins; and the anti-inflammatory drug tepoxalin, which killed via the multi-drug resistance protein ABCB1. The PRISM drug repurposing resource (https://depmap.org/repurposing) is a starting point to develop new oncology therapeutics, and more rarely, for potential direct clinical translation.

SUBMITTER: Corsello SM 

PROVIDER: S-EPMC7328899 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2019-08-08 | GSE133299 | GEO
| PRJNA551012 | ENA
| S-EPMC10751445 | biostudies-literature
| S-EPMC4406527 | biostudies-literature
| S-EPMC4720497 | biostudies-literature
| S-EPMC5102691 | biostudies-literature
| S-EPMC4096024 | biostudies-literature
| S-EPMC4583240 | biostudies-literature
| S-EPMC4268104 | biostudies-literature
| S-EPMC4341996 | biostudies-literature